North of England Dyspepsia Guideline Development Group. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales

JM Mason; Brendan Delaney; Paul Moayyedi; Mark Thomas; Robert Walt

doi:10.1111/j.1365-2036.2005.02445.x

North of England Dyspepsia Guideline Development Group. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales

JM Mason
, Brendan Delaney
, Paul Moayyedi
, Mark Thomas
, Robert Walt

Birmingham Medical School

Research output: Contribution to journal › Article

28 Citations (Scopus)

Original language	English
Pages (from-to)	1135-43
Number of pages	9
Journal	Alimentary Pharmacology & Therapeutics
Volume	21
Issue number	9
DOIs	https://doi.org/10.1111/j.1365-2036.2005.02445.x
Publication status	Published - 1 May 2005

Access to Document

10.1111/j.1365-2036.2005.02445.x

Cite this

@article{cd64b5cad1984fd1990007bc9a581e1c,

title = "North of England Dyspepsia Guideline Development Group. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales",

author = "JM Mason and Brendan Delaney and Paul Moayyedi and Mark Thomas and Robert Walt",

year = "2005",

month = may,

day = "1",

doi = "10.1111/j.1365-2036.2005.02445.x",

language = "English",

volume = "21",

pages = "1135--43",

journal = "Alimentary Pharmacology \& Therapeutics",

issn = "1365-2036",

publisher = "Wiley",

number = "9",

}

TY - JOUR

T1 - North of England Dyspepsia Guideline Development Group. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales

AU - Mason, JM

AU - Delaney, Brendan

AU - Moayyedi, Paul

AU - Thomas, Mark

AU - Walt, Robert

PY - 2005/5/1

Y1 - 2005/5/1

UR - https://www.scopus.com/pages/publications/18444389964

U2 - 10.1111/j.1365-2036.2005.02445.x

DO - 10.1111/j.1365-2036.2005.02445.x

M3 - Article

C2 - 15854176

SN - 1365-2036

VL - 21

SP - 1135

EP - 1143

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 9

ER -